Primary chemotherapy versus primary surgery for ovarian cancer Reply

被引：8

作者：

Kehoe, Sean ^{[1
]}

Nankivell, Matthew ^{[2
]}

机构：

[1] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England

[2] UCL, MRC, Clin Trials Unit, London WC2B 6NH, England

来源：

LANCET | 2015年 / 386卷 / 10009期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1016/S0140-6736(15)01052-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2143 / 2143

页数：1

共 2 条

[1] Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial [J].

Kehoe, Sean ;

Hook, Jane ;

Nankivell, Matthew ;

Jayson, Gordon C. ;

Kitchener, Henry ;

Lopes, Tito ;

Luesley, David ;

Perren, Timothy ;

Bannoo, Selina ;

Mascarenhas, Monica ;

Dobbs, Stephen ;

Essapen, Sharadah ;

Twigg, Jeremy ;

Herod, Jonathan ;

McCluggage, Glenn ;

Parmar, Mahesh ;

Swart, Ann-Marie .

LANCET, 2015, 386 (9990) :249-257

[2] Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer [J].

Vergote, Ignace ;

Trope, Claes G. ;

Amant, Frederic ;

Kristensen, Gunnar B. ;

Ehlen, Tom ;

Johnson, Nick ;

Verheijen, Rene H. M. ;

van der Burg, Maria E. L. ;

Lacave, Angel J. ;

Panici, Pierluigi Benedetti ;

Kenter, Gemma G. ;

Casado, Antonio ;

Mendiola, Cesar ;

Coens, Corneel ;

Verleye, Leen ;

Stuart, Gavin C. E. ;

Pecorelli, Sergio ;

Reed, Nick S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (10) :943-953

← 1 →